You have no items in your shopping cart.
Human ALK-1 [orb2995090]Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 37.6 KDa. Observed: 50-65 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Human TGFBR1 [orb2992807]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 37.2 KDa. Observed: 38-58 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse TGFBR3 [orb2993821]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 85.9 KDa. Observed: 110-125 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse TGFBR2 [orb2993827]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45 KDa. Observed: 60-75 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human LAP [orb2993832]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.5 KDa. Observed: 20-30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse TGFBR1 [orb2993858]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.6 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human LAP [orb2993077]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 31.4 KDa. Observed: 35-45 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human TGF-beta 3 [orb2993078]
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 12.7&35.3 KDa. Observed: 12&37-45 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human TGF-beta 2 [orb2993079]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.7&36 KDa. Observed: 13&39-50 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Mouse Latent TGF-beta 1 [orb2993080]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.8&31.7 KDa. Observed: 13&35-45 KDa, reducing conditions
100 μg, 20 μg